Literature DB >> 26231632

Clinical and Geographic Characterization of 30-Day Readmissions in Pediatric Sickle Cell Crisis Patients.

Jefferson E McMillan1, Emily R Meier2, Jeffrey C Winer3, Megan Coco2, Mary Daymont4, Sierra Long4, Brian R Jacobs5.   

Abstract

BACKGROUND AND OBJECTIVES: Sickle cell disease (SCD) is a blood disorder affecting many US children that is often associated with hospital readmission. Although previous studies have reported on the clinical factors that influence readmission risk, potential geographic factors have not been fully investigated. The goal of this study was to investigate the importance of geographic risk factors and to confirm previously derived clinical risk factors that influence readmissions for SCD pain crises.
METHODS: Retrospective analyses were performed on pediatric inpatients with sickle cell crises at a single center. Readmission rates and risk factors were assessed. Geospatial analysis was conducted on point variables that represented health service access, and multivariable logistic regression models were constructed.
RESULTS: The study identified 373 patients experiencing sickle cell crises, with 125 (33.5%) having at least one 30-day readmission. Age (mean difference: 2.2 years; P<0.001), length of stay (median difference: 1 day; P<.001), admission pain score>7 of 10 (odds ratio [OR]: 2.21; P<0.01), discharge pain score>4 of 10 (OR: 2.098; P<.01), living within 5 miles of the center's main hospital (OR: 0.573; P=.04), and >3 hospital utilizations in the previous 12 months (OR: 5.103; P<.001) were identified as potential indicators of 30-day readmission risk. Logistic regression models for 30-day readmissions yielded similar results.
CONCLUSIONS: Increased age, high admission and discharge pain scores, decreased length of stay, and increased hospital utilizations were found to be associated with an increased risk of readmission for sickle cell crisis. Patient's residence was also found to be a significant risk indicator, supporting the utility of geospatial analysis in assessing readmission risk.
Copyright © 2015 by the American Academy of Pediatrics.

Entities:  

Mesh:

Year:  2015        PMID: 26231632     DOI: 10.1542/hpeds.2014-0184

Source DB:  PubMed          Journal:  Hosp Pediatr        ISSN: 2154-1671


  5 in total

1.  Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.

Authors:  Ambroise Wonkam; Khuthala Mnika; Valentina J Ngo Bitoungui; Bernard Chetcha Chemegni; Emile R Chimusa; Collet Dandara; Andre P Kengne
Journal:  Br J Haematol       Date:  2017-12-03       Impact factor: 6.998

2.  Association of Guideline-Adherent Antibiotic Treatment With Readmission of Children With Sickle Cell Disease Hospitalized With Acute Chest Syndrome.

Authors:  David G Bundy; Troy E Richardson; Matthew Hall; Jean L Raphael; David C Brousseau; Staci D Arnold; Ram V Kalpatthi; Angela M Ellison; Suzette O Oyeku; Samir S Shah
Journal:  JAMA Pediatr       Date:  2017-11-01       Impact factor: 16.193

3.  Quantitative sensory testing is feasible and is well-tolerated in patients with sickle cell disease following a vaso-occlusive episode.

Authors:  Nitya Bakshi; Ines Lukombo; Inna Belfer; Lakshmanan Krishnamurti
Journal:  J Pain Res       Date:  2018-02-23       Impact factor: 3.133

4.  Machine Learning Readmission Risk Modeling: A Pediatric Case Study.

Authors:  Patricio Wolff; Manuel Graña; Sebastián A Ríos; Maria Begoña Yarza
Journal:  Biomed Res Int       Date:  2019-04-15       Impact factor: 3.411

5.  Risk Factors and Complications Among Pediatric Patients With Sickle Cell Anemia: A Single Tertiary Center Retrospective Study.

Authors:  Fatma Alzahrani; Anas M Fallatah; Fatimah M Al-Haddad; Shahad T Khayyat; Wasayf M AlMehmadi; Bashaier G AlQahtani; Rawabi S Alamri
Journal:  Cureus       Date:  2021-01-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.